Careful dose escalation, patient education (e.g., smaller meals, slower eating, avoiding highfat foods during titration), and proactive management of nausea and constipation can mitigate these effects and support adherence
The criteria for participation were: amenorrhea for 6+ months and not pregnant normal development no markers of metabolic disease weight stable for the last 12 months (noted that subjects were 5-9% below ideal weight) normal adrenal and thyroid hormones Patients were divided into two groups 10 patients with LH less than 3 IU/mL (average of 0.9 +/- 0.1) and 10 with LH greater than 3 IU/mL (average of 7.1 +/- 1.5)
Z., Loizidou, M., Ahmed, M
Our comprehensive approach ensures that you receive the most effective treatment tailored to your individual needs, supported by a team of experts committed to your success
The test identifies genetic variants in GLP1R, GIPR, FTO, and MC4R genes that influence how your body responds to semaglutide and how prone you are to menopause-related weight gain
Using telehealth services like Doctronic.ai allows you to start this process quickly and conveniently